Scribd
Upload
177 views1 page

Correspondence From DR Vladimir Zelenko On Treatment of COVID-19 in New York

Dr. Vladimir Zelenko wrote a letter describing his treatment of COVID-19 patients in Kiryas Joel, New York. He tested 200 people, 65% of whom tested positive, estimating over 20,000 total infections in the community. His outpatient treatment protocol for at-risk patients includes hydroxychloroquine, azithromycin, and zinc sulfate for 5 days. Of the 350 patients treated so far, there have been zero deaths, hospitalizations, or need for intubation. He recommends initiating this treatment as soon as possible based on his direct experience preventing severe illness.

Uploaded by

desitoronto
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
177 views1 page

Correspondence From DR Vladimir Zelenko On Treatment of COVID-19 in New York

Dr. Vladimir Zelenko wrote a letter describing his treatment of COVID-19 patients in Kiryas Joel, New York. He tested 200 people, 65% of whom tested positive, estimating over 20,000 total infections in the community. His outpatient treatment protocol for at-risk patients includes hydroxychloroquine, azithromycin, and zinc sulfate for 5 days. Of the 350 patients treated so far, there have been zero deaths, hospitalizations, or need for intubation. He recommends initiating this treatment as soon as possible based on his direct experience preventing severe illness.

Uploaded by

desitoronto
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Correspondence from Dr Vladimir Zelenko on Treatment of COVID-19 in New York

Dr. Vladimir (Zev) Zelenko


Board Certified Family Practitioner
501 Rt 208, Monroe, NY 10950
845-238-0000

March 23, 2020

To all medical professionals around the world:

My name is Dr. Zev Zelenko and I practice medicine in Monroe, NY. For the last 16 years, I have cared for approximately 75% of the adult population of Kiryas Joel, which is a very close knit community of approximately
35,000 people in which the infection spread rapidly and unchecked prior to the imposition of social distancing.

As of today my team has tested approximately 200 people from this community for Covid-19, and 65% of the results have been positive. If extrapolated to the entire community, that means more than 20,000 people are infected
at the present time. Of this group, I estimate that there are 1500 patients who are in the high-risk category (i.e. >60, immunocompromised, comorbidities, etc).

Given the urgency of the situation, I developed the following treatment protocol in the pre-hospital setting and have seen only positive results:

1. Any patient with shortness of breath regardless of age is treated.


2. Any patient in the high-risk category even with just mild symptoms is treated.
3. Young, healthy and low risk patients even with symptoms are not treated (unless their circumstances change and they fall into category 1 or 2).

My out-patient treatment regimen is as follows:

1. Hydroxychloroquine 200mg twice a day for 5 days


2. Azithromycin 500mg once a day for 5 days
3. Zinc sulfate 220mg once a day for 5 days

The rationale for my treatment plan is as follows. I combined the data available from China and South Korea with the recent study published from France (sites available on request). We know that hydroxychloroquine helps
Zinc enter the cell. We know that Zinc slows viral replication within the cell. Regarding the use of azithromycin, I postulate it prevents secondary bacterial infections. These three drugs are well known and usually well
tolerated, hence the risk to the patient is low.

Since last Thursday, my team has treated approximately 350 patients in Kiryas Joel and another 150 patients in other areas of New York with the above regimen.

Of this group and the information provided to me by affiliated medical teams, we have had ZERO deaths, ZERO hospitalizations, and ZERO intubations. In addition, I have not heard of any negative side effects other than
approximately 10% of patients with temporary nausea and diarrhea.

In sum, my urgent recommendation is to initiate treatment in the outpatient setting as soon as possible in accordance with the above. Based on my direct experience, it prevents acute respiratory distress syndrome (ARDS),
prevents the need for hospitalization and saves lives.

With much respect,

Dr. Zev Zelenko

cc: President Donald J. Trump; Mr. Mark Meadows, Chief of Staff

You might also like